Goserelin: Brand change
Goserelin is from a group of anti-hormonal medicines called gonadotropin-releasing hormone (GnRH) analogues.
The funded brand of goserelin is changing from Zoladex to Goserelin-Teva.
This change begins from 1 December 2020. There will be a five-month transition period, from 1 December 2020 until 1 May 2021.
When the new brand will be available
- From 1 December 2020 Goserelin-Teva will be fully funded and available for patients.
- From 1 May 2021 only Goserelin-Teva will be fully funded. Zoladex will no longer be funded.
If you want to stay on your current brand of goserelin, you can ask your pharmacist to check its price and availability. PHARMAC cannot guarantee the availability or price of Zoladex after 1 May 2021.
Goserelin-Teva works the same as Zoladex
- Goserelin-Teva works the same way as Zoladex.
- Goserelin-Teva has the same active ingredient which is delivered to the body in the same way.
- Goserelin-Teva has been evaluated by Medsafe to ensure it’s safe.
You shouldn’t notice any difference when you change to Goserelin-Teva.
If you have any questions about this change, talk with your doctor, nurse or pharmacist.
Your brand is changing to help us fund other medicines
A decision to change a medicine isn’t taken lightly. Our job is to make sure New Zealanders have access to the medicines they need. Making changes to medicines frees up our limited budget to help more New Zealanders access the medicines they need.
For healthcare professionals
You play an important role in supporting patients through changes to medicines. We’d like to support you as you help your patients with the change to goserelin.
There will be material for you to download closer to the transition period.
Key points to tell your patients about Goserelin-Teva
- Goserelin-Teva has the same active ingredient as Zoladex.
- The new brand is just as safe and works the same as the old brand.
- Patients shouldn’t notice any difference in how it affects them.
- Patients take Goserelin-Teva at the same frequency as Zoladex.
What is goserelin and what does it treat
Goserelin reduces levels of the sex hormones.
- In men, goserelin reduces levels of the male hormone, testosterone
- In women, it reduces the levels of the female hormone, oestrogen.
GnRH analogues are used to treat a range of conditions, including:
- prostate cancer
- breast cancer
- uterine fibroids
- central precocious puberty.
It is also used in assisted reproduction and to delay puberty in transgender youth.
Who to contact
If you have any questions about changing brands, talk with your doctor, nurse or pharmacist.
If you have questions about funding or access criteria:
- email firstname.lastname@example.org
- phone 0800 66 00 50.
Last updated: 31 July 2020